RituximabPneumonia and hypogammaglobulinaemia following off-label use of rituximab: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1841卷 / 1期

关键词：

D O I：

10.1007/s40278-021-90715-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：213 / 213

相关论文

共 50 条

[1] RituximabPneumonia following off label use: case report
Reactions Weekly, 2019, 1779 (1) : 207 - 207
[2] RituximabPneumonia with formation of pulmonary cavity following off-label therapy: case report
Reactions Weekly, 2020, 1835 (1) : 335 - 335
[3] RituximabMild tranfusion reaction following off-label use of rituximab: case report
Reactions Weekly, 2018, 1707 (1) : 241 - 241
[4] NivolumabFever following off-label use: case report
Reactions Weekly, 2016, 1601 (1) : 186 - 186
[5] RituximabPancytopenia following off-label use: case report
Reactions Weekly, 2020, 1807 (1) : 176 - 176
[6] TocilizumabAnaphylaxis following off-label use: case report
Reactions Weekly, 2021, 1865 (1) : 397 - 397
[7] DexamethasoneHyperglycaemia following off-label use: case report
Reactions Weekly, 2022, 1896 (1) : 173 - 173
[8] DexamfetamineHypertension following off-label use: case report
Reactions Weekly, 2021, 1883 (1) : 150 - 150
[9] FavipiravirNephrotoxicity following off-label use: case report
Reactions Weekly, 2022, 1929 (1) : 283 - 283
[10] MirtazapineTachyphylaxis following off-label use: case report
Reactions Weekly, 2018, 1703 (1) : 182 - 182

← 1 2 3 4 5 →